Evaluation of Adropin, Irisin and Cytokeratin 18 as Biomarkers in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Comparative Clinical Study.
The significant changes in their levels observed in MASLD patients suggest their possible application in multimarker diagnostic strategies. Nonetheless, the inconsistent behavior of Irisin in this study requires more conclusive evidence from future studies involving larger samples. Such biomarkers may help in identifying the disease at an early stage and improve the management of the disease.
Authors
- Suman Kumar Ray (ORCID: https://orcid.org/0000-0003-2019-962X)
- Abhishek Singhai (ORCID: https://orcid.org/0000-0002-3216-3387)
- Zirha Saleem
- Sukhes Mukherjee
- Sakshi Rai
- Deepa Roshni
Institutions
- All India Institute of Medical Sciences Bhopal (IN)
Publication Details
- Journal
- PubMed
- Published
- 2025-12-01
- Primary Topic
- Adipose Tissue and Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 0.00